Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Cancer
Published in: Journal of Gastrointestinal Cancer 2-3/2003

01-12-2003 | Research article

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas

Analysis of histopathology and outcome

Authors: Aaron R. Sasson, R. Wesley Wetherington, John P. Hoffman, Eric A. Ross, Harry Cooper, Neal J. Meropol, Gary Freedman, James F. Pingpank, Burton L. Eisenberg

Published in: Journal of Gastrointestinal Cancer | Issue 2-3/2003

Login to get access
Metadata
Title
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas
Analysis of histopathology and outcome
Authors
Aaron R. Sasson
R. Wesley Wetherington
John P. Hoffman
Eric A. Ross
Harry Cooper
Neal J. Meropol
Gary Freedman
James F. Pingpank
Burton L. Eisenberg
Publication date
01-12-2003
Publisher
Humana Press
Published in
Journal of Gastrointestinal Cancer / Issue 2-3/2003
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1385/IJGC:34:2-3:121

Other articles of this Issue 2-3/2003

Journal of Gastrointestinal Cancer 2-3/2003 Go to the issue

Clinical Trial

Cancer and leukemia group B (CALGB) 89805

Case Report

Carcinoma of the esophagus with mixed basaloid squamous and glandular differentiation

Case Report

Sub-acute sensory neuronopathy as a preceding sign of recurrence in colon carcinoma

Letter

Letter from the editor

Review Article

Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients

Case Report

Carcinoma of the cystic duct remnant with direct colonic invasion
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits